AbbVie pays $65M, with $1.4B chaser, for options on EvolveImmune's T-cell engagers 31.10.2024 16:30 Fiercebiotech.com AbbVie pays $65M, with $1.4B chaser, for options on EvolveImmune's T-cell engagers ntaylor Thu, 10/31/2024 - 09:30
